Skip to content

R&D at other companies

MicroStrategy logo
MicroStrategyMSTR
$24.67M+1.0%
Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
$8.25M-11.3%
CYP
Cypherpunk Technologies Inc. Common StockCYPH
$161K-98.8%
Regenxbio logo
RegenxbioRGNX
$57.34M+8.0%
Vor Biopharma logo
Vor BiopharmaVOR
$17.6M-34.1%

Other financials

Income statement

See full
Operating income-$36.9M-1,348%
Net income-$47.3M-1,763%
EPS (diluted)-$0.23+76.8%

Balance sheet

See full
Cash & equivalents$41.5M+3,760%
Total debt$1.4M0.0%
Total equity$469.8M+57,767%
Total assets$584.7M+35,093%

Cash flow

See full
Operating cash flow-$7.6M-184%

Valuation

See full
Market cap$217.49M+8.0%

Returns & leverage

See full
Return on equity-18%-8.6pp
Debt / equity0.3×
Current ratio37.7×+37.1×

Where this comes from

Reported directly by CNTN in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: CNTN’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNTN's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNTN's R&D?
CNTN (CNTN) reported R&D of $267.82K in Q1 2026.
How has CNTN's R&D changed year-over-year?
CNTN's R&D decreased by 54.9% year-over-year, from $594.07K to $267.82K.
What is the long-term trend for CNTN's R&D?
Over 4 years (2021 to 2025), CNTN's R&D has grown at a 13.0% compound annual growth rate (CAGR), from $1.88M to $3.07M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.